NCT03689595View on ClinicalTrials.gov

Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

RecruitingOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

October 31, 2018

Primary Completion Date

October 31, 2033

Study Completion Date

October 31, 2033

Conditions
Multiple Myeloma
Interventions
OTHER

Sample of Blood

Collection of blood sample from participants

Trial Locations (1)

02215

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER